Valenti Luca, Fracanzani Anna Ludovica, Dongiovanni Paola, Rovida Serena, Rametta Raffaela, Fatta Erika, Pulixi Edoardo Alessandro, Maggioni Marco, Fargion Silvia
Luca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, Serena Rovida, Raffaela Rametta, Erika Fatta, Edoardo Alessandro Pulixi, Silvia Fargion, Department of Pathophysiology and Transplantation, Metabolic Liver Diseases Research Center, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Policlinico, via F Sforza 35, 20122, Milano, Italy.
World J Gastroenterol. 2014 Mar 21;20(11):3002-10. doi: 10.3748/wjg.v20.i11.3002.
To compare iron depletion to lifestyle changes alone in patients with severe nonalcoholic fatty liver disease (NAFLD) and hyperferritinemia, a frequent feature associated with more severe liver damage, despite at least 6 mo of lifestyle changes.
Eligible subjects had to be 18-75 years old who underwent liver biopsy for ultrasonographically detected liver steatosis and hyperferritinemia, ferritin levels ≥ 250 ng/mL, and NAFLD activity score > 1. Iron depletion had to be achieved by removing 350 cc of blood every 10-15 d according to baseline hemoglobin values and venesection tolerance, until ferritin < 30 ng/mL and/or transferrin saturation (TS) < 25%. Thirty-eight patients were randomized 1:1 to phlebotomy (n = 21) or lifestyle changes alone (n = 17). The main outcome of the study was improvement in liver damage according to the NAFLD activity score at 2 years, secondary outcomes were improvements in liver enzymes [alanine aminotransferases (ALT), aspartate aminotransferase (AST), and gamma-glutamyl-transferases (GGT)].
Phlebotomy was associated with normalization of iron parameters without adverse events. In the 21 patients compliant to the study protocol, the rate of histological improvement was higher in iron depleted vs control subjects (8/12, 67% vs 2/9, 22%, P = 0.039). There was a better improvement in steatosis grade in iron depleted vs control patients (P = 0.02). In patients followed-up at two years (n = 35), ALT, AST, and GGT levels were lower in iron-depleted than in control patients (P < 0.05). The prevalence of subjects with improvement in histological damage or, in the absence of liver biopsy, ALT decrease ≥ 20% (associated with histological improvement in biopsied patients) was higher in the phlebotomy than in the control arm (P = 0.022). The effect of iron depletion on liver damage improvement as assessed by histology or ALT decrease ≥ 20% was independent of baseline AST/ALT ratio and insulin resistance (P = 0.0001).
Iron depletion by phlebotomy is likely associated with a higher rate of improvement of histological liver damage than lifestyle changes alone in patients with NAFLD and hyperferritinemia, and with amelioration of liver enzymes.
比较单纯生活方式改变与铁耗竭对严重非酒精性脂肪性肝病(NAFLD)合并高铁蛋白血症患者的影响,高铁蛋白血症是一种与更严重肝损伤相关的常见特征,尽管患者已进行了至少6个月的生活方式改变。
符合条件的受试者年龄在18 - 75岁之间,因超声检测到肝脏脂肪变性和高铁蛋白血症接受肝活检,铁蛋白水平≥250 ng/mL,NAFLD活动评分>1。根据基线血红蛋白值和放血耐受性,每10 - 15天抽取350 cc血液以实现铁耗竭,直至铁蛋白<30 ng/mL和/或转铁蛋白饱和度(TS)<25%。38例患者按1:1随机分为放血组(n = 21)或单纯生活方式改变组(n = 17)。该研究的主要结局是2年时根据NAFLD活动评分评估的肝损伤改善情况,次要结局是肝酶[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和γ-谷氨酰转移酶(GGT)]的改善情况。
放血与铁参数正常化相关且无不良事件。在21例遵循研究方案的患者中,铁耗竭组的组织学改善率高于对照组(8/12,67%对2/9,22%,P = 0.039)。铁耗竭组患者的脂肪变性分级改善优于对照组(P = 0.02)。在两年随访的患者(n = 35)中,铁耗竭组患者的ALT、AST和GGT水平低于对照组(P < 0.05)。放血组组织学损伤改善或在未进行肝活检时ALT降低≥20%(活检患者中与组织学改善相关)的受试者患病率高于对照组(P = 0.022)。通过组织学或ALT降低≥20%评估,铁耗竭对肝损伤改善的作用独立于基线AST/ALT比值和胰岛素抵抗(P = 0.0001)。
对于NAFLD合并高铁蛋白血症患者,与单纯生活方式改变相比,放血导致的铁耗竭可能与更高的肝脏组织学损伤改善率相关,并能改善肝酶水平。